Effect of nirmatrelvir/ritonavir on calcineurin inhibitor levels: Early experience in four SARS-CoV-2 infected kidney transplant recipients

Am J Transplant. 2022 Aug;22(8):2117-2119. doi: 10.1111/ajt.16997. Epub 2022 Feb 23.
No abstract available

Keywords: clinical research/practice; drug interaction; immunosuppressant - calcineurin inhibitor (CNI); infection and infectious agents-viral: SARS-CoV-2/COVID-19; infectious disease; pharmacology; solid organ transplantation.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Drug Treatment*
  • Calcineurin Inhibitors / therapeutic use
  • Humans
  • Kidney Transplantation* / adverse effects
  • Ritonavir / therapeutic use
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Calcineurin Inhibitors
  • Ritonavir